TNFSF13B and systemic lupus erythematosus: This post hoc meta-analysis of two previous phase 3 SLE studies aimed to explore the relationship between BLyS mRNA levels and/or IFN-1 mRNA status and clinical responses to IV belimumab (10 mg/kg) treatment in the SLE population.